Dr Reddy's Resolves Legacy Issues At Duvvada After FDA Clears Plant

Dr Reddy’s has been given the all-clear for its Indian formulations manufacturing facility in Duvvada, Visakhapatnam, after the FDA issued an EIR closing out an inspection at the plant that has suffered longstanding quality issues.

Silhouette
After years of quality issues, Reddy's Duvvada site is cleared by FDA • Source: Shutterstock

Dr Reddy’s has been given the all-clear for its Indian formulations manufacturing facility in Duvvada, Visakhapatnam, after obtaining an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for the site that has been dealing with manufacturing setbacks since a 2015 warning letter.

The Duvvada site was included in an FDA warning letter issued to Reddy’s in November 2015 that also highlighted issues...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business